About this Journal Submit a Manuscript Table of Contents
International Journal of Medicinal Chemistry
Volume 2013 (2013), Article ID 348948, 16 pages
http://dx.doi.org/10.1155/2013/348948
Review Article

Synthetic Methods, Chemistry, and the Anticonvulsant Activity of Thiadiazoles

1Institute of Pharmacy, Bundelkhand University, Jhansi 284128, India
2Department of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom Institute of Agriculture, Technology and Sciences-Deemed University, Allahabad 211007, India

Received 5 December 2012; Revised 8 February 2013; Accepted 12 February 2013

Academic Editor: Hussein El-Subbagh

Copyright © 2013 Bhawna Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Loscher, “New visions in the pharmacology of anticonvulsion,” European Journal of Pharmaceutical Sciences, vol. 342, pp. 1–13, 1998. View at Publisher · View at Google Scholar
  2. A. Gringauz, John Wiley & Sons, New York, NY, USA, 1st edition, 1997.
  3. M. J. Brodie, “Monotherapy trials: prerequisite data,” Epilepsy Research, vol. 45, no. 1–3, pp. 61–64, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. R. H. Mattson, “Efficacy and adverse effects of established and new antiepileptic drugs,” Epilepsia, vol. 36, supplement 2, pp. S13–S26, 1995. View at Publisher · View at Google Scholar
  5. A. Demirbas, D. Sahin, N. Demirbas, and S. A. Karaoglu, “Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities,” European Journal of Medicinal Chemistry, vol. 44, no. 7, pp. 2896–2903, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. R. T. Morrison and R. N. Boyd, Organic Chemistry, Prentice Hall, New Delhi, India, 6th edition, 2005.
  7. T.-B. Wei, H. Liu, J.-H. Hu, et al., “Microwave promoted efficient synthesis of 2,5-disubstituted 1,3,4-thiadiazole,” Indian Journal of Chemistry B, vol. 45, pp. 2754–2756, 2006.
  8. J. Goerdler, J. Ohm, and O. Tegmeyer, “Darstellung und Eigenschaften des 1.2.4- und des 1.3.4-Thiodiazols,” Chemische Berichte, vol. 89, pp. 1534–1543, 1956. View at Publisher · View at Google Scholar
  9. A. R. Katritzky and R. Charlews, in Comprehensive Heterocyclic Chemistry, vol. 6, pp. 568–575, Ist edition, 1984.
  10. E. Formm, E. Layer, and K. Nerz, Advances in Heterocyclic Chemistry, vol. 9, p. 188, 1968.
  11. H. B. Koing and H. A. Ofle, Chemical Abstracts, vol. 53, p. 10253, 1957.
  12. British Patent, Chemical abstract, 59, 1650, 916061, 1963.
  13. F. Kurzer, “Thiadiazoles. Part XI. Synthesis and cyclisation of N-(thiobenzamido)guanidines and related compounds,” Journal of the Chemical Society, vol. 1961, pp. 1617–1625, 1961.
  14. R. R. Gupta, M. Kumar, and V. Gupta, Heterocyclic Chemistry Springen, vol. 2, pp. 566–573, 2005.
  15. G. Young and W. Eyne, “III.—Oxidation of benzalthiosemicarbazone,” Journal of the Chemical Society, Transactions, vol. 79, pp. 54–60, 1901.
  16. J. Y. Hweng, H. Choi, D. H. Lee, and Y. D. Gong, “Solid-phase synthesis of 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives via selective, reagent-based cyclization of acyldithiocarbazate resins,” Journal of Combinatorial Chemistry, vol. 7, pp. 816–819, 2005. View at Publisher · View at Google Scholar
  17. P. C. Guha, “Ring closure of hydrazodithio- and -monothio-dicarbonamides with acetic anhydride,” Journal of the American Chemical Society, vol. 45, pp. 1036–1042, 1923. View at Publisher · View at Google Scholar
  18. T. A. Bachetti and B. J. Banieli, Advances in Heterocyclic Chemistry, vol. 9, p. 1711, 1968.
  19. J. Goerdeler and H. Hanbrich, “Über die Kupplungsaktivität einiger heterocyclischer Diazoverbindungen,” Chemische Berichte, vol. 93, pp. 397–405, 1960. View at Publisher · View at Google Scholar
  20. M. Otha, H. Oya, and A. J. Miture, Charm Soc Japan Chemical Abstract, vol. 48, p. 10006, 1953.
  21. C. J. Anisworth, “The investigation of some substituted 1,3,4-thiadiazoles,” Journal of the American Chemical Society, vol. 80, no. 19, p. 5201, 1958. View at Publisher · View at Google Scholar
  22. F. F. Medovschikowa and I. Y. Postovskii, Journal of Heterocyclic Chemistry, vol. 9, p. 197, 1968.
  23. H. Sai Kachi and M. Kanaka, Yakugakuzasthi Chemi Abstract, vol. 58, p. 4543, 1963.
  24. H. Sai Kachi and M. Kanaka, Yakugakuzasthi, vol. 58, p. 7304, 1962.
  25. S. N. Swamy, Basappa, B. S. Priya et al., “Synthesis ofpharmaceutically important condensed heterocyclic 4,6-disubstituted-1,2,4-triazolo-1,3,4-thiadiazole derivatives asantimicrobials,” European Journal of Medicinal Chemistry, vol. 41, no. 4, pp. 531–538, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Hussain, J. Sharma, and M. Amir, “Synthesis and antimicrobial activities of 1,2,4-triazole and 1,3,4-thiadiazole derivatives of 5-amino-2-hydroxybenzoic acid,” E-Journal of Chemistry, vol. 5, no. 4, pp. 963–968, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. A. Aly and R. E. Sayed, “Synthesis and biological activity of new 1,3,4-thiadiazole derivatives,” Chemical Papers, vol. 60, no. 1, pp. 56–60, 2006. View at Publisher · View at Google Scholar
  28. R. Dua and S. K. Srivastava, “Synthesis, characterization and antimicrobial activity,” International Journal of Pharma and Bio Sciences, vol. 1, no. 2, 2010.
  29. F. Hadizadeh and R. Vosooghi, “Synthesis of α-[5-(5-amino-1,3,4-thiadiazol-2-yl)-2-imidazolylthio] acetic acids,” Journal of Heterocyclic Chemistry, vol. 45, no. 5, pp. 1477–1479, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Salimon, N. Salih, A. Hameed, H. Ibraheem, and E. Yousif, “Synthesis and antibacterial activity of some new 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives,” Journal of Applied Sciences Research, vol. 6, no. 7, pp. 866–870, 2010. View at Scopus
  31. A. M. Qandil, H. N. Tumah, and M. A. Hassan, “Synthesis and antibacterial activity of N4-benzoyl-N 1-dihydroxybenzoylthiosemicarbazides and their cyclic 1,3,4-thiadiazole derivatives,” Acta Pharmaceutica Sciencia, vol. 48, no. 2, pp. 95–107, 2006. View at Scopus
  32. R. S. Lamani, N. S. Shetty, R. R. Kambl, and A. M. Khazi, “Synthesis and antimicrobial studies of novel methylene bridged benzisoxazolyl imidazo[2,1-b][1,3,4]thiadiazole derivatives,” European Journal of Medicinal Chemistry, vol. 44, pp. 2828–2833, 2008. View at Publisher · View at Google Scholar
  33. A. Foroumadi, S. Emami, A. Hassanzadeh et al., “Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2- yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 20, pp. 4488–4492, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Onkol, D. S. Doruer, L. Uzun, S. Adak, S. Ozkan, and M. F. Ahin, “Synthesis and antimicrobial activity of new 1,2,4-triazole and 1,3,4-thiadiazole derivatives,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 23, no. 2, pp. 277–284, 2008. View at Publisher · View at Google Scholar
  35. N. Siddiqui and M. S. Alam, “5-(1H-indol-3-ylmethyl)-N-(substituted phenyl)-1,2,4-thiadiazol-2-amine derivatives: synthesis and biological screening,” Biosciences Biotechnology Research Asia, vol. 6, no. 1, pp. 261–264, 2009.
  36. P. Karegoudar, D. J. Prasad, M. Ashok, M. Mahalinga, B. Poojary, and B. S. Holla, “Synthesis, antimicrobial and anti-inflammatory activities of some 1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazines bearing trichlorophenyl moiety,” European Journal of Medicinal Chemistry, vol. 43, no. 4, pp. 808–815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Karabasanagouda, A. V. Adhikari, and N. S. Shetty, “Synthesis and antimicrobial activities of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines carrying thioalkyl and sulphonyl phenoxy moieties,” European Journal of Medicinal Chemistry, vol. 42, no. 4, pp. 521–529, 2007. View at Publisher · View at Google Scholar
  38. V. Mathew, J. Keshavayya, V. P. Vaidya, and D. Giles, “Studies on synthesis and pharmacological activities of 3,6-disubstituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and their dihydro analogues,” European Journal of Medicinal Chemistry, vol. 42, no. 6, pp. 823–840, 2007. View at Publisher · View at Google Scholar
  39. C. J. Chen, B. A. Song, S. Yang et al., “Synthesis and antifungal activities of 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-thiadiazole and 5-(3,4,5-trimethoxyphenyl)-2-sulfonyl-1,3,4-oxadiazole derivatives,” Bioorganic and Medicinal Chemistry, vol. 15, pp. 3981–3989, 2007. View at Publisher · View at Google Scholar
  40. H. S. Chen, H. S. LI, H. S. Z, Y. F. Han, and Z. W. Wang, “New fungicidally active pyrazolyl-substituted 1,3,4-thiadiazole compounds and their preparation,” Chinese Chemical Letters, vol. 10, no. 5, pp. 365–366, 1999.
  41. M. Barboiu, M. Cimpoesu, C. Guran, and C. T. Supumn, “1,3,4-thiadiazole derivatives. Part 91. Synthesis and biological activity of metal complexes of 5-(2-aminoethyl)-2-amino-1,3,4-thiadiazole,” Metal Based Drugs, vol. 3, no. 5, pp. 227–232, 1996. View at Publisher · View at Google Scholar
  42. S. R. Pattan, P. kekare, N. S. Dighe et al., “Synthesis and biological evaluation of some 1,3,4-thiadiazoles,” Journal of Chemical and Pharmaceutical Research, vol. 1, no. 1, pp. 191–198, 2009.
  43. M. Amir, H. Kumar, and S. A. Javed, “Condensed bridgehead nitrogen heterocyclic system: Synthesis and pharmacological activities of 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives of ibuprofen and biphenyl-4-yloxy acetic acid,” European Journal of Medicinal Chemistry, vol. 43, no. 10, pp. 2056–2066, 2008. View at Publisher · View at Google Scholar
  44. M. Amir, H. Kumar, and S. A. Javed, “Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives of naproxen,” Bioorganic and Medicinal Chemistry Letters, vol. 17, pp. 4504–4508, 2007. View at Publisher · View at Google Scholar
  45. L. S. Varandas, C. A. M. Fraga, A. L. P. Miranda, and E. J. Barreiro, “Design, synthesis and pharmacological evaluation of new nonsteroidal antiinflammatory 1,3,4-thiadiazole derivatives,” Letters in Drug Design and Discovery, vol. 2, no. 1, pp. 62–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Moise, V. Sunel, L. Profire, M. Popa, J. Desbrieres, and C. Peptu, “Synthesis and biological activity of some new 1,3,4-thiadiazole and 1,2,4-triazole compounds containing a phenylalanine moiety,” Molecules, vol. 14, no. 7, pp. 2621–2631, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Kumar, S. A. Javed, S. A. Khan, and M. Amir, “1,3,4-Oxadiazole/thiadiazole and 1,2,4-triazole derivatives of biphenyl-4-yloxy acetic acid: Synthesis and preliminary evaluation of biological properties,” European Journal of Medicinal Chemistry, vol. 43, no. 12, pp. 2688–2698, 2008. View at Publisher · View at Google Scholar
  48. S. Schenone, C. Brullo, O. Bruno et al., “New 1,3,4-thiadiazole derivatives endowed with analgesic and anti-inflammatory activities,” Bioorganic and Medicinal Chemistry, vol. 14, no. 6, pp. 1698–1705, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. S. G. Kucukguzel, I. Kucukguze, I. E. Tatar et al., “Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents,” European Journal of Medicinal Chemistry, vol. 42, no. 7, pp. 893–901, 2007. View at Publisher · View at Google Scholar
  50. M. A. Hilfiker, N. Wang, X. Hou et al., “Discovery of novel aminothiadiazole amides as selective EP3 receptor antagonists,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 15, pp. 4292–4295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. A. K. Gadad, M. B. Palkar, K. Anand, M. N. Noolvi, T. S. Boreddy, and J. Wagwade, “Synthesis and biological evaluation of 2-trifluoromethyl/sulfonamido-5,6-diaryl substituted imidazo[2,1-b]-1,3,4-thiadiazoles: a novel class of cyclooxygenase-2 inhibitors,” Bioorganic and Medicinal Chemistry, vol. 16, no. 1, pp. 276–283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. U. S. Goksen, N. G. Kelekci, O. Goktas et al., “1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities,” Bioorganic and Medicinal Chemistry, vol. 15, no. 17, pp. 5738–5751, 2007. View at Publisher · View at Google Scholar
  53. A. S. Kalgutar, A. B. Marnett, B. C. Crews, R. P. Remmel, and L. J. Marnett, “Ester and Amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors,” Journal of Medicinal Chemistry, vol. 43, no. 15, pp. 2860–2870, 2000. View at Publisher · View at Google Scholar
  54. M. Duflos, M. R. Nourrisson, J. Brelet et al., “N-Pyridinyl-indole-3-(alkyl)carboxamides and derivatives as potential systemic and topical inflammation inhibitors,” European Journal of Medicinal Chemistry, vol. 36, no. 6, pp. 545–553, 2001. View at Publisher · View at Google Scholar · View at Scopus
  55. V. J. Ram, A. Goel, and M. Kandpal, “Tetraazaacenaphthene, tetraazaphenalene and 1,3,4-thiadiazole derivatives as potential leishmanicides,” Bioorganic and Medicinal Chemistry Letters, vol. 7, no. 6, pp. 651–656, 1997. View at Publisher · View at Google Scholar
  56. E. F. da Silva, M. M. Canto-Cavalheiro, V. R. Braz, L. Cysne-Finkelstein, L. L. Leon, and A. Echevarria, “Synthesis, and biological evaluation of new 1,3,4-thiadiazolium-2-phenylamine derivatives against Leishmania amazonensis promastigotes and amastigotes,” European Journal of Medicinal Chemistry, vol. 37, no. 12, pp. 979–984, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Behrouzi-Fardmoghadam, F. Poorrajab, S. K. Ardestani, S. Emami, A. Shafiee, and A. Foroumadi, “Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines,” Bioorganic and Medicinal Chemistry, vol. 16, no. 8, pp. 4509–4515, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Foroumadi, S. Emami, S. Pournourmohammadi, A. Kharazmi, and A. Shafiee, “Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H- imidazol-2-yl)-5-substituted-1,3,4-thiadiazole derivatives,” European Journal of Medicinal Chemistry, vol. 40, no. 12, pp. 1346–1350, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Karakus and S. Rollas, “Synthesis and antituberculosis activity of new N-phenyl-N′-[4-(5-alkyl/arylamino-1,3,4-thiadiazole-2-yl)phenyl]thioureas,” Il Farmaco, vol. 57, no. 7, pp. 577–581, 2002. View at Publisher · View at Google Scholar
  60. E. E. Oruc, S. Rollas, F. Kandermirli, N. Shvets, and A. S. Dimoglo, “1,3,4-thiadiazole derivatives. Synthesis, structure elucidation, and structure−antituberculosis activity relationship investigation,” Journal of Medicinal Chemistry, vol. 47, pp. 6760–6676, 2004. View at Publisher · View at Google Scholar
  61. A. Foroumadi, Z. Kargar, A. Sakhteman et al., “Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3, 4-thiadiazol-2-ylthio]propionates,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 5, pp. 1164–1167, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Karakus, U. Coruh, B. Barlas-Durgun et al., “Synthesis and cytotoxic activity of some 1,2,4-triazoline-3-thione and 2,5-disubstituted-1,3,4-thiadiazole derivatives,” Marmara Pharmaceutical Journal, vol. 14, no. 2, pp. 84–90, 2010.
  63. J. Matysiak and A. Opolski, “Synthesis and antiproliferative activity of N-substituted 2-amino-5-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles,” Bioorganic and Medicinal Chemistry, vol. 14, no. 13, pp. 4483–4489, 2006. View at Publisher · View at Google Scholar
  64. V. Padmavathi, G. Sudhakar Reddy, A. Padmaja, P. Kondaiah, and Ali-Shazia, “Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles,” European Journal of Medicinal Chemistry, vol. 44, no. 5, pp. 2106–2112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. M. X. Wei, L. Feng, X. Q. Li, X. Z. Zhou, Z.-H. Shao, and H. Shao, “Synthesis of new chiral 2,5-disubstituted 1,3,4-thiadiazoles possessing γ-butenolide moiety and preliminary evaluation of in vitro anticancer activity,” European Journal of Medicinal Chemistry, vol. 44, no. 8, pp. 3340–3344, 2009. View at Publisher · View at Google Scholar
  66. D. A. Ibrahim, “Synthesis and biological evaluation of 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as a novel class of potential anti-tumor agents,” European Journal of Medicinal Chemistry, vol. 44, pp. 2776–2781, 2009. View at Publisher · View at Google Scholar
  67. J. Matysiak, A. Nasulewicz, M. Pelczynska, M. Switalska, I. Jaroszewicz, and A. Opolski, “Synthesis and antiproliferative activity of some 5-substituted 2-(2,4-dihydroxyphenyl)-1,3,4-thiadiazoles,” European Journal of Medicinal Chemistry, vol. 41, pp. 475–482, 2006. View at Publisher · View at Google Scholar
  68. A. T. Mavrova, D. Wesselinova, Y. A. Tsenov, and P. Denkova, “Synthesis, cytotoxicity and effects of some 1,2,4-triazole and 1,3,4-thiadiazole derivatives on immunocompetent cells,” European Journal of Medicinal Chemistry, vol. 44, no. 1, pp. 63–69, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Zhan, X. Liu, Z. Li et al., “Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: synthesis and preliminary SAR studies,” Bioorganic and Medicinal Chemistry, vol. 17, pp. 5920–5927, 2009. View at Publisher · View at Google Scholar
  70. P. Zhan, X. Liu, Z. Fang, Z. Li, C. Pannecouque, and E. D. Clercq, “Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1,2,3-thiadiazol-5-ylthio)-N-acetamides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors,” European Journal of Medicinal Chemistry, vol. 44, pp. 4648–4653, 2009. View at Publisher · View at Google Scholar
  71. C. Kus, G. A. Kilcigil, S. Ozbey et al., “Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol-2-amine and 4-methyl-2H-1,2,4-triazole-3(4H)-thione derivatives of benzimidazole class,” Bioorganic and Medicinal Chemistry, vol. 16, pp. 4294–4303, 2008. View at Publisher · View at Google Scholar
  72. S. Dhanya, A. M. Isloor, P. Shetty, K. Satyamoorthy, and A. S. Bharath Prasad, Arabian Journal of Chemistry. In press.
  73. D. Cressier, C. Prouillac, P. Hernandez et al., “Synthesis, antioxidant properties and radioprotective effects of new benzothiazoles and thiadiazoles,” Bioorganic and Medicinal Chemistry, vol. 17, no. 14, pp. 5275–5284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. V. Dudutien, L. Baranauskien, and D. Matulis, “Benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides as inhibitors of carbonic anhydrase,” Bioorganic and Medicinal Chemistry Letters, vol. 17, pp. 3335–3338, 2007. View at Publisher · View at Google Scholar
  75. G. L. Almajan, A. Innocenti, L. Puccetti et al., “Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols,” Bioorganic and Medicinal Chemistry Letters, vol. 15, no. 9, pp. 2347–2352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Mirzaei, F. Siavoshi, S. Emami et al., “Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2-yl]thiomorpholines and related compounds,” European Journal of Medicinal Chemistry, vol. 43, no. 8, pp. 1575–1580, 2008. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Foroumadi, A. Rineh, S. Emami et al., “Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 11, pp. 3315–3320, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Gupta, P. Mishra, S. K. Kashaw, V. Jatav, and J. P. Stables, “Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Δ2-1,2,4-thiadiazoline,” European Journal of Medicinal Chemistry, vol. 43, no. 4, pp. 749–754, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Gupta, P. Mishra, S. N. Pandeya, S. K. Kashaw, V. Kashaw, and J. P. Stables, “Synthesis and anticonvulsant activity of some substituted 1,2,4-thiadiazoles,” European Journal of Medicinal Chemistry, vol. 44, no. 3, pp. 1100–1105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  80. M. S. Yar and M. W. Akhter, “Synthesis and anticonvulsant activity of substituted oxadiazole and thiadiazole derivatives,” Acta Poloniae Pharmaceutica, vol. 66, no. 4, pp. 393–397, 2009. View at Scopus
  81. B. Ahamad and M. Yusuf, “synthesis of aromatic aldehyde imine derivative of 2-thiobenzyl-1,3,4-thiadiazole and evaluation of their anticonvulsant activity,” Indian Journal of Chemistry B, vol. 49, pp. 241–246, 2010.
  82. V. Jatav, P. Mishra, S. Kashaw, and J. P. Stables, “CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones,” European Journal of Medicinal Chemistry, vol. 43, pp. 1945–1954, 2008. View at Publisher · View at Google Scholar
  83. H. N. Dogan, A. Duran, S. Rollas, G. Sener, M. K. Uysal, and D. Gulen, “Synthesis of new 2,5-disubstituted-1,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities,” Bioorganic & Medicinal Chemistry, vol. 10, no. 9, pp. 2893–2898, 2002.
  84. A. Varvaresou, T. Siatra-Papastaikoudi, A. Tsotinis, A. T. Kakoulidou, and A. Vamvakides, “Synthesis, lipophilicity and biological evaluation of indole-containing derivatives of 1,3,4-thiadiazole and 1,2,4-triazole,” Il Farmaco, vol. 53, no. 5, pp. 320–326, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Foroumadi, V. Sheibani, A. Sakhteman et al., “Synthesis and anticonvulsant activity of novel 2-amino-5-[4-chloro-2-(2- chlorophenoxy) phenyl]-1,3,4-thiadiazole derivatives,” Daru Journal of Pharmaceutical Sciences, vol. 15, no. 2, pp. 89–93, 2007. View at Scopus
  86. X. Q. Deng, Z. Q. Dong, M. X. Song, B. Shu, S. B. Wang, and Z. S. Quan, “Synthesis and anticonvulsant activities of some triazolothiadiazole derivatives,” Archiv der Pharmazie, vol. 345, no. 7, pp. 565–573, 2012. View at Publisher · View at Google Scholar
  87. M. R. Stillings, P. W. Anthony, and S. W. Donald, “Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 2. Aminoalkyl derivatives,” Journal of Medicinal Chemistry, vol. 29, no. 11, pp. 2280–2284, 1986. View at Publisher · View at Google Scholar
  88. N. Siddiqui, A. Rana, S. Khan et al., “Synthesis and preliminary screening of benzothiazol-2-yl thiadiazole derivatives for anticonvulsant activity,” Acta Pharmaceutica, vol. 59, no. 4, pp. 441–451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. N. Siddiqui, S. Ali, S. A. Khan, S. Drabu, A. Rana, and M. Alam, “Synthesis of 3-arylamino-4-aryl-5-(N-arylthiocarbonylimino)-4, 5-dihydro-1,2,4-thiadiazoles as anticonvulsant agents,” Indian Journal of Heterocyclic Chemistry, vol. 14, no. 2, pp. 159–160, 2004. View at Scopus
  90. N. Siddiqui, M. F. Arshad, S. A. Khan, and W. Ahsan, “Synthesis, anticonvulsant and neurotoxicity screening of 1-(substituted phenyl)-3-[(5-substituted phenyl)-1,3,4-thiadiazole-2-yl]-2- thioxodihydro pyrimidine-4,6 (1H, 5H)-diones,” Journal of Pharmaceutical Research, vol. 7, no. 2, pp. 122–125, 2008.
  91. P. Mullick, S. A. Khan, S. Verma, and O. Alam, “Thiadiazole derivatives as potential anticonvulsant agents,” Bulletin of the Korean Chemical Society, vol. 32, no. 3, pp. 1011–1016, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. C. B. Chapleo, P. L. Mayers, J. F. Saville et al., “Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 1. Hydrazines,” Journal of Medicinal Chemistry, vol. 29, no. 11, pp. 2273–2280, 1986. View at Publisher · View at Google Scholar
  93. H. Rajak, C. K. Behera, R. S. Pawar, P. K. Singour, and M. D. Kharya, “Synthesis and anticonvulsant evaluation of some novel 2,5-disubstituted 1,3,4-thiadiazoles: pharmacophore model studies,” Acta Poloniae Pharmaceutica, vol. 67, no. 5, pp. 503–510, 2010. View at Scopus
  94. M. D. Kamal, H. A. Gawad, E. A. Rageb, M. Ellithey, and H. A. Mohamed, “Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles,” Bioorganic and Medicinal Chemistry, vol. 14, no. 11, pp. 3672–3680, 2006.